Agilent Highlights Integrated Automation Solutions at SLAS 2022
04 Fevereiro 2022 - 10:00AM
Business Wire
Powerful modular solutions providing deeper research
insights
Agilent Technologies Inc. (NYSE: A) highlights innovative
laboratory automation solutions at the SLAS2022 International
Conference and Exhibition held February 5 through February 9, 2022,
at the Boston Convention and Exhibition Center in Boston,
Massachusetts.
Agilent modular automation solutions address a wide array of
cell analysis, mass spectrometry, and genomics workflows in both
development and regulated environments. Overall, sample preparation
is more straightforward, more accurate, and more efficient,
ensuring better reproducibility, fewer replicates, faster results,
and safer data.
“Agilent’s modular automation platforms deliver powerful
solutions to meet the exceptional needs of our customers,” said
Sudharshana Seshadri, vice president and general manager of
Agilent's Mass Spec Division. “Our consultative approach –
including application-specific workflow solutions – allows
researchers to focus on results and gain deeper insights that will
accelerate their research and ultimately their understanding of the
human condition.”
Agilent integrated automation solutions highlighted at SLAS will
include the BioTek BioSpa Live Cell Analysis System. This system
comprises of a BioTek Cytation C10 Confocal Imaging Reader,
combining automated confocal and widefield microscopy with
conventional multi-mode microplate reading, and a BioTek BioSpa 8
Automated Incubator. This product combination provides fully
automated live cell imaging workflows in up to eight microplates at
a time.
Other integrated automation solutions on show include Agilent’s
Bravo automation portfolio, powered by compliance-enabled VWorks
version 14.1. VWorks automation control software provides a single,
intuitive user interface that simplifies and drives laboratory
automation integration. This powerful and easy-to-use software
connects diverse Agilent and BioTek devices. These include the
BenchCel Workstation, an automated microplate handler; the Bravo, a
flexible liquid handling platform; readers, imagers, dispensers,
and washers into one cohesive, integrated system ensuring maximum
throughput and optimal resource utilization.
The new AssayMAP Bravo software and large capacity cartridges
enable the AssayMAP Bravo to be used more efficiently during
development and in regulated environments such as QA/QC. The new
software also simplifies documentation and method transfer between
groups so projects can be moved quickly forward through the
biologics development path.
To learn more about these innovative automation solutions, SLAS
attendees are invited to visit Agilent's Exhibition Booth No. 2022
at the Boston Convention and Exhibition Center.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in the
life sciences, diagnostics, and applied chemical markets,
delivering insight and innovation that advance the quality of life.
Agilent’s full range of solutions includes instruments, software,
services, and expertise that provide trusted answers to our
customers' most challenging questions. The company generated
revenue of $6.32 billion in fiscal 2021 and employs 17,000 people
worldwide. Information about Agilent is available at
www.agilent.com. To receive the latest Agilent news, please
subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn,
Twitter, and Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220204005237/en/
Media Contact Naomi Goumillout Agilent Technologies
+1.781.266.2819 naomi.goumillout@agilent.com
Agilent Technologies (NYSE:A)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Agilent Technologies (NYSE:A)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024